First Time Loading...

Ascendis Pharma A/S
NASDAQ:ASND

Watchlist Manager
Ascendis Pharma A/S Logo
Ascendis Pharma A/S
NASDAQ:ASND
Watchlist
Price: 131.14 USD 6.75% Market Closed
Updated: May 23, 2024

Ascendis Pharma A/S
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ascendis Pharma A/S
Free Cash Flow Peer Comparison

Comparables:
GMAB
ZEAL
B
BAVA
BIOPOR
SANION

Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Ascendis Pharma A/S
NASDAQ:ASND
Free Cash Flow
-€321.8m
CAGR 3-Years
-2%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Genmab A/S
CSE:GMAB
Free Cash Flow
kr5.4B
CAGR 3-Years
1%
CAGR 5-Years
49%
CAGR 10-Years
N/A
Zealand Pharma A/S
CSE:ZEAL
Free Cash Flow
-kr449.4m
CAGR 3-Years
14%
CAGR 5-Years
1%
CAGR 10-Years
-10%
B
Bavarian Nordic A/S
CSE:BAVA
Free Cash Flow
kr1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
78%
Bioporto A/S
CSE:BIOPOR
Free Cash Flow
-kr49.9m
CAGR 3-Years
-4%
CAGR 5-Years
-4%
CAGR 10-Years
-11%
Saniona AB
STO:SANION
Free Cash Flow
-kr85.7m
CAGR 3-Years
22%
CAGR 5-Years
-29%
CAGR 10-Years
N/A

See Also

What is Ascendis Pharma A/S's Free Cash Flow?
Free Cash Flow
-321.8m EUR

Based on the financial report for Mar 31, 2024, Ascendis Pharma A/S's Free Cash Flow amounts to -321.8m EUR.

What is Ascendis Pharma A/S's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-14%

Over the last year, the Free Cash Flow growth was 39%. The average annual Free Cash Flow growth rates for Ascendis Pharma A/S have been -2% over the past three years , -14% over the past five years .